IP Verse

Intranasal Epinephrine Formulations And Methods For The Treatment Of Disease - EP3678649

The patent EP3678649 was granted to Aegis Therapeutics on Dec 21, 2022. The application was originally filed on Feb 6, 2019 under application number EP19751807A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3678649

AEGIS THERAPEUTICS
Application Number
EP19751807A
Filing Date
Feb 6, 2019
Status
Granted And Under Opposition
Sep 23, 2022
Grant Date
Dec 21, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

AERAJul 24, 2023ADMISSIBLE

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONAT386414B
DESCRIPTIONUS2015005356
DESCRIPTIONUS2015374832
DESCRIPTIONUS2017216199
DESCRIPTIONUS5369095
DESCRIPTIONWO2011139838
DESCRIPTIONWO2015095389
INTERNATIONAL-SEARCH-REPORTUS2015005356
INTERNATIONAL-SEARCH-REPORTUS2015374832
OPPOSITIONUS2018169247
SEARCHUS2017216199
SEARCHUS5369095
SEARCHWO2011139838
SEARCHWO2015095389

Non-Patent Literature (NPL) Citations (20) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- AUNGST BJ, AAPS Journal, (20110000), vol. 14, no. 1, pages 10 - 8-
DESCRIPTION- BERGE et al., Journal of Pharmaceutical Sciences, (19770000), vol. 66, pages 1 - 19-
DESCRIPTION- CAS, no. 51-43-4-
DESCRIPTION- GRUBER, H.GREBER, G., "Reactive Sucrose Derivatives", Carbohydrates as Organic Raw Materials, pages 95 - 116-
DESCRIPTION- MAGGIO, ET, Excipients and Food Chem., (20140000), vol. 5, no. 2, pages 100 - 12-
DESCRIPTION- MAGGIO, J. Excipients and Food Chem., (20140000), vol. 5, no. 2, pages 100 - 12-
DESCRIPTION- NAKPONETON et al., J. Allergy Clin Immunol, (20100000), vol. 125, no. 2-
DESCRIPTION- OZSOY et al., Molecules, (20090000), vol. 14, pages 3754 - 79-
DESCRIPTION- SIMONS et al., "Epinephrine absorption in adults: Intramuscular versus subcutaneous injection", J Allergy. Clin. Immunol., (20010000), vol. 108, pages 871 - 3-
DESCRIPTION- SRISAWAT C et al., "A preliminary study of intranasal epinephrine administration as a potential route for anaphylaxis treatment", Asian Pac J Allergy Immunol, (20160300), vol. 34, no. 1, pages 38 - 43-
DESCRIPTION- SRISAWAT et al., Asian Pac J Allergy Immuno, (20160000), vol. 34, pages 38 - 43-
DESCRIPTION- VIDGRENKUBLIK, Adv. Drug Deliv. Rev., (19980000), vol. 29, pages 157 - 77-
INTERNATIONAL-SEARCH-REPORT- "Adrenalin Chloride Nasal Solution (epinephrine nasal solution, USP", PAR Pharmaceuticals, (20150000), URL: http://www.parsterileproducts.com/products/products/adrenalin-chloride-solution.php, XP055631104 [A] 1-3, 41-44-
INTERNATIONAL-SEARCH-REPORT- NAKPONETONG et al., "Pharmacokinetics Of Epinephrine Absorption via Intranasal Administration: A Preliminary Report", J ALLERGY CLIN IMMUNOL, (20100000), vol. 125, no. 2, XP026902261 [X] 41-44 * , Abstract 859. RESULTS *
OPPOSITION- Anonymous, "Guidance for Industry Nasal Spray and Inhalation Solution, Suspension, and Spray Drug Products — Chemistry, Manufacturing, and Controls Documentation", U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER), (20020701), pages 1 - 45, U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER), URL: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm070575.pdf, (20150528), XP055191926-
OPPOSITION- Anonymous, "Semi-rigid hinge for an idler scraper", Research Disclosure, Kenneth Mason Publications, Hampshire, UK, GB, GB , (20000801), vol. 436, no. 88, ISSN 0374-4353, XP007126635-
OPPOSITION- Chatchawan Srisawat, Kanittha Nakponetong, Patchanee Benjasupattananun, Chanthana Suratannon, Leatchai Wachirutmanggur, Siribangon Boonchoo, Duangjai Pankaew, Apirom Laocharoenkiat, Punchama Pacharn, Orathai Jirapongsananuruk, Nualanong Visitsunthorn, Pakit Vichyanond, "A preliminary study of intranasal epinephrine administration as a potential route for anaphylaxis treatment", Asian Pacific journal of allergy and immunology, The Allergy and Immunology Society, Thailand, Thailand , (20160301), page 38, Asian Pacific journal of allergy and immunology, URL: http://apjai-journal.org/wp-content/uploads/2016/10/27408-39845-6-PB.pdf, XP055728595-
OPPOSITION- Gerald K. McEvoy, "Epinephrine hydrochloride...", Gerald K. McEvoy, Gerald K. McEvoy, Elaine K. Snow, Jane Miller, HANDBOOK ON INJECTABLE DRUGS, 19th Edition, American Society of Health System Pharmacists, (20170101), pages 467 - 473, ISBN 978-1-58528-559-4, XP009555998-
OPPOSITION- Edward T. Maggio, Dennis J. Pillion, "High efficiency intranasal drug delivery using Intravail® alkylsaccharide absorption enhancers", DRUG DELIVERY AND TRANSLATIONAL RESEARCH, SPRINGER, Germany, Germany , (20130201), vol. 3, no. 1, doi:10.1007/s13346-012-0069-z, ISSN 2190-393X, pages 16 - 25, XP055370902
SEARCH- Chatchawan Srisawat ET AL, "A preliminary study of intranasal epinephrine administration as a potential route for anaphylaxis treatment", Asian Pacific journal of allergy and immunology, Thailand, (20160301), page 38, URL: http://apjai-journal.org/wp-content/uploads/2016/10/27408-39845-6-PB.pdf, XP055728595 [Y] 1-19 * the whole document *-

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents